From Yahoo Finance: 2025-06-15 09:59:00

In May, the S&P 500 rebounded, but some stocks crashed due to specific concerns. One healthcare giant withdrew its 2025 outlook, while another faced a drug trial setback. Both stocks are worth watching now. UnitedHealth Group plunged 26.6% last month due to CEO resignation and Medicare Advantage costs. The company refutes allegations and aims for growth in 2026. Regeneron Pharmaceuticals lost 18.2% in May after a drug trial failure. The company has a robust pipeline and recently initiated a dividend. It was outbid by the former CEO of 23andMe. Consider 10 better stocks than UnitedHealth Group, identified by The Motley Fool Stock Advisor team. Their top picks have outperformed the S&P 500 significantly. Don’t miss the latest top 10 list for potential monster returns.

Read more: These Were the 2 Worst-Performing Stocks in the S&P 500 in May 2025